These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9709085)

  • 1. Pharmacotherapy of acid-peptic disorders.
    Burkard PG
    Lippincotts Prim Care Pract; 1998; 2(4):398-409. PubMed ID: 9709085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician.
    Huang JQ; Hunt RH
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):355-70. PubMed ID: 11403532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [25 years of gastric acid blockers].
    Lamers CB
    Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2501-4. PubMed ID: 10627749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New therapeutic options in the treatment of GERD and other acid-peptic disorders. Based on a presentation by Duane D. Webb, MD, FACG.
    Am J Manag Care; 2000 May; 6(9 Suppl):S467-75. PubMed ID: 10977486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost analysis of a provincial drug program to guide the treatment of upper gastrointestinal disorders.
    Bursey F; Crowley M; Janes C; Turner CJ
    CMAJ; 2000 Mar; 162(6):817-23. PubMed ID: 10750472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in the diagnostic yield of upper gastrointestinal endoscopy in dyspeptic patients receiving proton-pump inhibitors and H2-receptor antagonists.
    Mitchell RM; Collins JS; Watson RG; Tham TC
    Endoscopy; 2002 Jul; 34(7):524-6. PubMed ID: 12170401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of dyspepsia and peptic ulcer disease.
    Ryan SW
    Altern Ther Health Med; 2005; 11(5):26-9; quiz 30. PubMed ID: 16189945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review article: the pharmacodynamics and pharmacokinetics of proton pump inhibitors--overview and clinical implications.
    Robinson M
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 6():1-10. PubMed ID: 15496213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of proton pump inhibitors in NSAID-associated gastropathy and upper gastrointestinal symptoms.
    Laine L
    Rev Gastroenterol Disord; 2003; 3 Suppl 4():S30-9. PubMed ID: 14671512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of a Helicobacter pylori treatment strategy on health care expenditures in patients with peptic ulcer disease and dyspepsia.
    Kearney DJ; Liu CF; Crump C; Brousal A
    Am J Gastroenterol; 2003 Sep; 98(9):1952-62. PubMed ID: 14499771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic acid-related disorders are common and underinvestigated.
    Majumdar SR; Soumerai SB; Farraye FA; Lee M; Kemp JA; Henning JM; Schrammel P; LeCates RF; Ross-Degnan D
    Am J Gastroenterol; 2003 Nov; 98(11):2409-14. PubMed ID: 14638341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs.
    McCarthy DM
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):755-73. PubMed ID: 11566039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H2-receptor antagonists.
    Nurs Times; 2004 Nov 2-8; 100(44):33. PubMed ID: 15552489
    [No Abstract]   [Full Text] [Related]  

  • 14. A randomized controlled trial of test-and-treat strategy for Helicobacter pylori: clinical outcomes and health care costs in a managed care population receiving long-term acid suppression therapy for physician-diagnosed peptic ulcer disease.
    Allison JE; Hurley LB; Hiatt RA; Levin TR; Ackerson LM; Lieu TA
    Arch Intern Med; 2003 May; 163(10):1165-71. PubMed ID: 12767952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The limitations of current therapy in peptic ulcer disease.
    Salena BJ; Hunt RH
    Clin Invest Med; 1987 May; 10(3):171-7. PubMed ID: 3304747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptic ulcer disease in pregnancy.
    Michaletz-Onody PA
    Gastroenterol Clin North Am; 1992 Dec; 21(4):817-26. PubMed ID: 1478737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lansoprazol ++ : a new proton pump inhibitor].
    Baczek J; Laskowiec G
    Pol Merkur Lekarski; 1998 Jun; 4(24):339-41. PubMed ID: 9771021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical use of antacids.
    Halter F
    J Physiol Pharmacol; 1993 Sep; 44(3 Suppl 1):61-74. PubMed ID: 8260736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current indications for acid suppressants in dyspepsia.
    Bytzer P; Talley NJ
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):385-400. PubMed ID: 11403534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term course of reflux symptoms following Helicobacter pylori eradication].
    Peitz U; Raps S; Plein K; Leodolter A; Hotz Dagger J; Malfertheiner P
    Dtsch Med Wochenschr; 2004 Mar; 129(13):671-5. PubMed ID: 15026962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.